Stay updated with breaking news from Highlight Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 million Gross profit amounted to RMB738.5 million Adjusted...
HONG KONG, March 28, 2024 /PRNewswire/ -- Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net...
Existing backers of Taihe Weiye including GL Ventures, CICC Capital, and GF Xinde Investment re-upped in the financing round.
DealStreetAsia's editors recap the week's developments and highlights in our award-winning Sunday newsletter.
Temasek, its wholly-owned subsidiary True Light Capital, and HighLight Capital have invested around $210 million in Chinad's VIVA Biotech.